• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病患者应用重组人促红细胞生成素纠正贫血前后的诱发电位

Evoked potentials before and after anemia correction with recombinant human erythropoietin in end-stage renal disease.

作者信息

Suppiej A, Montini G, Casara G, Polo A, Zacchello G, Zacchello F

机构信息

Department of Pediatrics, University of Padova, Italy.

出版信息

Child Nephrol Urol. 1992;12(4):197-201.

PMID:1473092
Abstract

Subclinical involvement of the nervous system in uremic adults has been detected by modern neurophysiological techniques. Chronic anemia is one of the possible factors responsible for neural dysfunction in uremia. We evaluated neurophysiological (brainstem auditory and somatosensory evoked potential) abnormalities and their possible modification following anemia correction with recombinant human erythropoietin in 14 children with end-stage renal disease maintained by hemodialysis. Only peripheral and 8th cranial nerve electrophysiological data are significantly abnormal in our patients, and they are not acutely modified by anemia correction. These data confirm the importance of electrophysiological testing of uremic children for detecting nervous system involvement at an early stage and for monitoring the efficacy of its management.

摘要

现代神经生理学技术已检测出尿毒症成年患者存在神经系统的亚临床受累情况。慢性贫血是导致尿毒症神经功能障碍的可能因素之一。我们评估了14例接受血液透析维持治疗的终末期肾病患儿的神经生理学(脑干听觉和体感诱发电位)异常情况,以及使用重组人促红细胞生成素纠正贫血后这些异常情况可能发生的变化。在我们的患者中,仅外周和第8对脑神经的电生理数据显著异常,且贫血纠正后这些数据并未发生急性改变。这些数据证实了对尿毒症患儿进行电生理检测对于早期发现神经系统受累情况以及监测其治疗效果的重要性。

相似文献

1
Evoked potentials before and after anemia correction with recombinant human erythropoietin in end-stage renal disease.终末期肾病患者应用重组人促红细胞生成素纠正贫血前后的诱发电位
Child Nephrol Urol. 1992;12(4):197-201.
2
[Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].[重组人促红细胞生成素治疗持续性非卧床腹膜透析儿童尿毒症贫血]
Pol Tyg Lek. 1994;49(6-7):135-6.
3
Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.重组人促红细胞生成素纠正贫血后透析患者左心室肥厚的消退
Can J Cardiol. 1990 Jan-Feb;6(1):1-4.
4
Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
Semin Nephrol. 1990 Mar;10(2 Suppl 1):26-7.
5
Setting up an 'EPO' system. Management of patients receiving recombinant human erythropoietin.建立“促红细胞生成素(EPO)”系统。接受重组人促红细胞生成素治疗患者的管理。
Prof Nurse. 1992 Feb;7(5):282-3, 286-7.
6
Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.生活质量:重组人促红细胞生成素治疗带来的主观和客观改善。
Semin Nephrol. 1989 Mar;9(1 Suppl 1):22-9.
7
Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
Contrib Nephrol. 1988;66:94-103.
8
Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
Transplant Proc. 1991 Apr;23(2):1827-30.
9
Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.重组人促红细胞生成素在血液透析患者中的临床疗效
Semin Nephrol. 1989 Mar;9(1 Suppl 1):16-21.
10
Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.重组人促红细胞生成素对红细胞生成的剂量相关效应。终末期肾病患者多中心试验结果
Contrib Nephrol. 1988;66:85-93.

引用本文的文献

1
Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review.促红细胞生成素刺激剂在慢性肾病儿童中的应用:一项系统评价
Clin Kidney J. 2022 Feb 26;15(8):1483-1505. doi: 10.1093/ckj/sfac058. eCollection 2022 Aug.